/

Other

/

Aerie Pharmaceuticals

Aerie Pharmaceuticals

Aerie Pharmaceuticals

Verified Nov 2026

Other

·

United States flag

Durham, North Carolina

·

Since 2005

Aerie Pharmaceuticals develops ophthalmic therapies for glaucoma and dry eye disease. Founded in 2005 and headquartered in Durham, North Carolina, the company operated as a clinical-stage pharmaceutical firm with 100–200 employees before its acquisition by Swiss eye-care firm Alcon in 2025. Its marketed products include Rhopressa and Rocklatan, once-daily eye drop therapies designed to lower intraocular pressure.

Aerie Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

2005

Headquarters

United States flag

Durham, North Carolina

Employees

100-200

Ownership

Aerie Pharmaceuticals at a glance

Employees

100-200

Founded

2005

Headquarters

Durham, North Carolina

Industries

Automotive

Electric Vehicles

Medical

Overview

Aerie Pharmaceuticals develops ophthalmic therapies for glaucoma and dry eye disease. Founded in 2005 and headquartered in Durham, North Carolina, the company operated as a clinical-stage pharmaceutical firm with 100–200 employees before its acquisition by Swiss eye-care firm Alcon in 2025. Its marketed products include Rhopressa and Rocklatan, once-daily eye drop therapies designed to lower intraocular pressure.

At a glance

Attribute

Detail

Founded

2005

Headquarters

Durham, North Carolina

Employees

100-200

What Aerie Pharmaceuticals makes

The company develops once-daily eye drop therapies with novel mechanisms for lowering intraocular pressure, and its product portfolio includes treatments for glaucoma and dry eye disease.

Latest developments

Facilities

Aerie Pharmaceuticals is headquartered in Durham, North Carolina. Public sources also reference these locations:

Company details

Following its acquisition by Alcon, Aerie's therapies are now distributed through Alcon's network, expanding their reach within the global ophthalmic pharmaceutical market. Aerie Pharmaceuticals was founded in 2005, has an estimated 100-200 employees, and is headquartered in Durham, North Carolina.

Frequently asked questions

What does Aerie Pharmaceuticals do?

Aerie Pharmaceuticals develops ophthalmic therapies for glaucoma and dry eye disease. Founded in 2005 and headquartered in Durham, North Carolina, the company operated as a clinical-stage pharmaceutical firm with 100–200 employees before its acquisition by Swiss eye-care firm Alcon in 2025. Its marketed products include Rhopressa and Rocklatan, once-daily eye drop therapies designed to lower intraocular pressure.

Where is Aerie Pharmaceuticals headquartered?

Aerie Pharmaceuticals is headquartered in Durham, North Carolina (4301 Emperor Blvd, Durham, North Carolina, 27703-7615).

When was Aerie Pharmaceuticals founded?

Aerie Pharmaceuticals was founded in 2005.

How big is Aerie Pharmaceuticals?

Aerie Pharmaceuticals has an estimated 100-200 employees.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Durham, North Carolina (HQ)Headquarters · United States
Durham, North Carolina (HQ)4301 Emperor Blvd, Durham, North Carolina, 27703-7615, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.